Mostrando 8 resultados de: 8
Filtros aplicados
Publisher
Applied Sciences (Switzerland)(1)
Cell and Bioscience(1)
Frontiers in Aging Neuroscience(1)
International Journal of Biological Sciences(1)
Journal of Nanobiotechnology(1)
Área temáticas
Enfermedades(8)
Farmacología y terapéutica(5)
Medicina y salud(5)
Fisiología humana(4)
Ginecología, obstetricia, pediatría, geriatría(2)
Origen
scopus(8)
A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer’s disease exacerbated with high fat diet
ArticleAbstract: Background: Alzheimer’s disease (AD) is characterized by a polyetiological origin. Despite the globaPalabras claves:Alzheimer’s disease, BACE1, BDNF, cognitive decline, dendritic spines, high-fat diet, neuroinflammation, Rhein-huprine hybrid, Tau, TLR4Autores:Antoni Camins, Auladell C., Bulló M., Cano A., Espinosa-Jimenez T., Ettcheto M., Folch J., Muñoz-Torrero D., Olloquequi J., Parcerisas A., Pont C., Sanchez-Lopez E., Verdaguer E.Fuentes:scopusExtracellular vesicles, the emerging mirrors of brain physiopathology
ArticleAbstract: Extracellular vesicles are secreted by a wide variety of cells, and their primary functions includePalabras claves:Alzheimer’s disease, exosomes, Extracellular vesicles, Glioblastoma, multiple sclerosis, amyotrophic lateral sclerosis, neurodegenerative diseases, Parkinson’s DiseaseAutores:Antoni Camins, Bernuz M., Boada M., Cano A., de Antonio E.E., Ettcheto M., Martí M., Pividori M.I., Puerta R., Ruíz A., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopusNanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges
ReviewAbstract: Increasing life expectancy has led to an aging population, which has consequently increased the prevPalabras claves:Alzheimer’s disease, Biomarkers, lipid nanoparticles, Metal nanoparticles, nanotechnology, Polymeric nanoparticlesAutores:Antoni Camins, Boada M., Cano A., Duskey J.T., Ettcheto M., García M.L., Marquié M., Ruiz A., Sanchez-Lopez E., Souto E.M.B., Tosi G., Turowski P.Fuentes:scopusMetformin a potential pharmacological strategy in late onset Alzheimer’s disease treatment
ReviewAbstract: Alzheimer’s disease (AD) is one of the most devastating brain disorders. Currently, there are no effPalabras claves:Alzheimer’s disease, AMP activated protein kinase AMPK, Beta amyloid, diabetes mellitus, Insulin Resistance, Metformin, Tau protein hyperphosphorylationAutores:Antoni Camins, Cano A., Ettcheto M., Javan M., Manzine P.R., Olloquequi J., Poor S.R., Sanchez-Lopez E.Fuentes:scopusPeripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer’s Disease
ArticleAbstract: There is growing evidence that obesity associated with type 2 diabetes mellitus (T2DM) and aging arePalabras claves:Alzheimer’s disease, APPswe/PS1dE9, DIABÉTES, high-fat diet, Memantine, obesityAutores:Antoni Camins, Auladell C., Busquets O., Cabrera H., Carro E., Casadesús G., Ettcheto M., Folch J., García M.L., Gómez-Mínguez Y., Sanchez-Lopez E., Vázquez-Carrera M., Zárate C.B.Fuentes:scopusPolymeric nanoparticles as drug delivery systems for dementia
Book PartAbstract: Dementia affects around 50 million people worldwide and it is one of the main causes of disability aPalabras claves:Alzheimer’s disease, dementia, drug delivery, Nanomedicine, PLGA, Polymeric nanoparticlesAutores:Antoni Camins, Cano A., Espina M., Esteruelas G., Ettcheto M., García M.L., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopusSurface functionalization of plga nanoparticles to increase transport across the bbb for alzheimer’s disease
ReviewAbstract: Alzheimer’s disease (AD) is a chronic neurodegenerative disorder that accounts for about 60% of allPalabras claves:Alzheimer’s disease, blood-brain barrier, Brain delivery, Functionalized PLGA nanoparticlesAutores:Amo L.D., Antoni Camins, Cano A., Espina M., Ettcheto M., García M.L., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopusThe Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
ReviewAbstract: Nowadays, Alzheimer’s disease (AD) is a severe sociological and clinical problem. Since it was firstPalabras claves:Alzheimer’s disease, Insulin Resistance, Mediterranean diet, neuroinflammation and neurodegeneration, obesity, Type 2 Diabetes mellitusAutores:Antoni Camins, Auladell C., Bulló M., Busquets O., Cano A., Casadesús G., Espinosa-Jimenez T., Ettcheto M., Folch J., García M.L., Olloquequi J., Sanchez-Lopez E., Zárate C.B.Fuentes:scopus